Injection of 99mTc-nanocolloid and ICG to Identify, Retrieve and Qualify TDLN in Early-stage NSCLC

NACompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

October 3, 2022

Primary Completion Date

October 31, 2024

Study Completion Date

October 31, 2024

Conditions
Early-stage Lung Cancer
Interventions
RADIATION

99mTc-nanocolloid

Injection of 99mTc-nanocolloid when lung cancer is diagnosed during a navigation bronchoscopy, followed by one or two SPECT/CT-scans.

DRUG

ICG

If patient undergoes surgery to treat the lung cancer, ICG will be injected and retrieved fluorescent lymph nodes will undergo additional pathological assessment.

Trial Locations (1)

6525 GA

Radboudumc, Nijmegen

Sponsors
All Listed Sponsors
collaborator

Philips Healthcare

INDUSTRY

collaborator

Johnson & Johnson

INDUSTRY

lead

Radboud University Medical Center

OTHER